(Q24202407)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

1 reference

title

Interventions for actinic keratoses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

3

0 references

author name string

Aditya K Gupta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Maryse Paquet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

William Brintnell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Elmer Villanueva

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

12 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

CD004415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

Short‐course therapy with imiquimod 5% cream for solar keratoses: A randomized controlled trial

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Topical diclofenac in hyaluronan gel for the treatment of solar keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Facial resurfacing for nonmelanoma skin cancer prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Topical diclofenac/hyaluronic acid gel in the treatment of solar keratoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Randomized, double-blinded, placebo controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Effectiveness of cross polarized light and fluorescence diagnosis for detection of sub-clinical and clinical actinic keratosis during imiquimod treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Ingenol mebutate gel for actinic keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

A phase II dose-ranging study of topical resiquimod to treat actinic keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Efficacy of imiquimod as an adjunct to cryotherapy for actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Reduction of solar keratoses by regular sunscreen use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Photodynamic therapy of multiple actinic keratoses: reduced pain through use of visible light plus water-filtered infrared A compared with light from light-emitting diodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Safety and efficacy of dose-intensive oral vitamin A in subjects with sun-damaged skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Laser-Mediated Photodynamic Therapy of Actinic Keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Twice daily vs. four times daily 5-fluorouracil therapy for actinic keratoses: a split face study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Cryopeeling for treatment of photodamage and actinic keratosis: liquid nitrogen versus portable system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

The effect of increasing fluence on the treatment of actinic keratosis and photodamage by photodynamic therapy with 5-aminolevulinic acid and intense pulsed light

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Effectiveness of 5-fluorouracil treatment for actinic keratosis--a systematic review of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Medical therapies for non-melanoma skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis").

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

The treatment of actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Health Effects of Sunlight Exposure in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

High incidence and regression rates of solar keratoses in a queensland community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Disappointing results following resurfacing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

The risk of progression to invasive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Continuing medical education article-skin treatment: Photodynamic therapy: indications and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Imiquimod for actinic keratosis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Solar keratosis: epidemiology, pathogenesis, presentation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Actinic keratosis. Current treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Photodynamic therapy of cancer. Basic principles and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Milestones in the development of photodynamic therapy and fluorescence diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Actinic keratosis: epidemiology and progression to squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Impact of interval and combination therapies on the management of actinic keratosis: review and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Clinical presentation of actinic keratoses and squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Pathology and pathobiology of actinic (solar) keratosis - an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Epidemiology of actinic keratoses and squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

A prospective study of the use of cryosurgery for the treatment of actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Management of field change in actinic keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Topical imiquimod: mechanism of action and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004415.PUB2

Topical colchicine therapy for actinic keratoses

21 January 2018

1 reference

12 December 2020

Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine

1 reference

12 December 2020

Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer.

1 reference

12 December 2020

Aminolevulinic acid hydrochloride with photodynamic therapy: efficacy outcomes and recurrence 4 years after treatment

1 reference

12 December 2020

Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses

1 reference

12 December 2020

Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks

1 reference

12 December 2020

The use of topical fluorouracil to treat actinic keratosis

1 reference

12 December 2020

Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis.

1 reference

12 December 2020

Actinic keratoses: new treatment options.

1 reference

12 December 2020

Pulse therapy with 5-FU in eradicating actinic keratoses with less than recommended dosage

1 reference

12 December 2020

Short incubation PDT versus 5-FU in treating actinic keratoses

1 reference

12 December 2020

Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses

1 reference

12 December 2020

Topical treatment of actinic keratosis with fluorouracil: is irritation associated with efficacy?

1 reference

12 December 2020

Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream.

1 reference

12 December 2020

One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study

1 reference

12 December 2020

Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp

1 reference

12 December 2020

Mechanisms of action of new treatment modalities for actinic keratosis.

1 reference

12 December 2020

In vitro and in vivo comparison of two different light sources for topical photodynamic therapy

1 reference

12 December 2020

Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients

1 reference

12 December 2020

Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage

1 reference

12 December 2020

A clinical comparison and long-term follow-up of topical 5-fluorouracil versus laser resurfacing in the treatment of widespread actinic keratoses

1 reference

12 December 2020

Frequency and Cost of Actinic Keratosis Treatment

1 reference

12 December 2020

Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: a randomized, double-blind, placebo controlled study

1 reference

12 December 2020

Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp

1 reference

12 December 2020

Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis

1 reference

12 December 2020

Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head

1 reference

12 December 2020

Split-face-study using two different light sources for topical PDT of actinic keratoses:non-inferiority of the LED system

1 reference

12 December 2020

Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.

1 reference

12 December 2020

A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck

1 reference

12 December 2020

Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study

1 reference

12 December 2020

Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy.

1 reference

12 December 2020

Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream

1 reference

12 December 2020

Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis

1 reference

12 December 2020

Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report.

1 reference

12 December 2020

Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses

1 reference

12 December 2020

Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study

1 reference

12 December 2020

Chemopreventive efficacy of topical difluoromethylornithine and/or triamcinolone in the treatment of actinic keratoses analyzed by karyometry.

1 reference

12 December 2020

Use of pyruvic acid in the treatment of actinic keratoses: a clinical and histopathologic study.

1 reference

12 December 2020

Nonsurgical innovations in the treatment of nonmelanoma skin cancer

1 reference

12 December 2020

Actinic keratoses: a comprehensive update

1 reference

12 December 2020

A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses.

1 reference

12 December 2020

Liquid nitrogen: temperature control in the treatment of actinic keratosis

1 reference

12 December 2020

A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp

1 reference

12 December 2020

Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream

1 reference

12 December 2020

Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: a randomized, intraindividual comparison trial with 12-month follow-up

1 reference

12 December 2020

Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses

1 reference

12 December 2020

Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications

1 reference

12 December 2020

The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy

1 reference

12 December 2020

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo

1 reference

12 December 2020

Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm

1 reference

12 December 2020

A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes

1 reference

12 December 2020

Health effects of sunlight exposure in the United States. Results from the first National Health and Nutrition Examination Survey, 1971-1974.

1 reference

12 December 2020

Effect of intralesional alpha 2-interferon on actinic keratoses

1 reference

12 December 2020

Topical chemotherapy of actinic keratoses of the upper extremity with tretinoin and 5-fluorouracil: a double-blind controlled study

1 reference

12 December 2020

Fluorouracil: mechanism of action in human skin and actinic keratoses. I. Effect on DNA synthesis in vivo

1 reference

12 December 2020

Etretinate in treatment of actinic keratosis. A double-blind crossover study

1 reference

12 December 2020

1 reference

12 December 2020

Angiostasis and vascular regression in chronic granulomatous inflammation induced by diclofenac in combination with hyaluronan in mice

1 reference

12 December 2020

High sun protection factor sunscreens in the suppression of actinic neoplasia

1 reference

12 December 2020

Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses

1 reference

12 December 2020

Actinic keratosis. A premalignant skin lesion.

1 reference

12 December 2020

Beta-1,3-D-glucan gel in the treatment of solar keratoses

1 reference

12 December 2020

1 reference

12 December 2020

The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan

1 reference

12 December 2020

The actinic keratosis. A perspective and update

1 reference

12 December 2020

Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light

1 reference

12 December 2020

The new fluor-hydroxy pulse peel. A combination of 5-fluorouracil and glycolic acid

1 reference

12 December 2020

A clinicopathological study of the effects of topical retinyl propionate cream in skin photoageing

1 reference

12 December 2020

Noninflammatory destruction of actinic keratoses by fluorouracil

1 reference

12 December 2020

10.1002/14651858.CD004415.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

3330238

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

3330238

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235610%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

2 references

Consolidated OpenCitations Corpus – April 2017

3330238